Additional Chromosome Structural Aberrations Are Associated with Poorer Clinical Outcomes in Multiple Myeloma Patients with Hyperdiploidy

被引：0
|
作者：
Carballo-Zarate, Adrian
Medeiros, L. Jeffrey
Hao, Suyang
Orlowski, Robert
Lin, Pei
Lu Xinyan
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Houston Methodist Hosp, Houston, TX USA
来源：
MODERN PATHOLOGY | 2016年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1341
引用
收藏
页码：338A / 338A
页数：1
相关论文
共 50 条
  • [31] Aberrations Detected By FISH in Brazilian Multiple Myeloma Patients
    Chauffaille, Maria de Lourdes
    Borgo Perazzio, Aline Dos Santos
    BLOOD, 2019, 134
  • [32] Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib
    Acikalin, Arbil
    Bagir, Emine Kilic
    Paydas, Semra
    Alsancak, Perihan
    Ergin, Melek
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (02): : 395 - 401
  • [33] Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities
    Lim, Ji-Hun
    Seo, Eul-Ju
    Park, Chan-Jeoung
    Jang, Seongsoo
    Chi, Hyun-Sook
    Suh, Cheolwon
    Kim, Hawk
    Kim, Sung-Ryul
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (04) : 313 - 320
  • [34] Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients
    Wang, Tongtong
    Geng, Chuanying
    Yang, Guangzhong
    Zhou, Huixing
    Zhang, Zhiyao
    Jian, Yuan
    Chen, Wenming
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (17-18)
  • [35] Outcomes and management of lenalidomide-associated rash in patients with multiple myeloma
    Barley, Kevin
    He, Wei
    Agarwal, Shradha
    Jagannath, Sundar
    Chari, Ajai
    LEUKEMIA & LYMPHOMA, 2016, 57 (11) : 2510 - 2515
  • [36] Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
    Alexanian, R
    Weber, D
    Delasalle, K
    Handy, B
    Champlin, R
    Giralt, S
    BONE MARROW TRANSPLANTATION, 2004, 34 (03) : 229 - 234
  • [37] Impact of Beta Blocker on Clinical Outcomes of Multiple Myeloma (MM) Patients
    Hwa, Yi Lisa
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis
    Rajkumar, S. Vincent
    Kumar, Shaji
    Kapoor, Prashant
    Go, Ronald S.
    Hayman, Suzanne R.
    Lin, Yi
    Lust, John A.
    Dingli, David
    Russell, Stephen J.
    Gonsalves, Wilson I.
    Dispenzieri, Angela
    BLOOD, 2014, 124 (21)
  • [38] Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
    R Alexanian
    D Weber
    K Delasalle
    B Handy
    R Champlin
    S Giralt
    Bone Marrow Transplantation, 2004, 34 : 229 - 234
  • [39] Clinical outcomes of venous thromboembolism with dalteparin therapy in multiple myeloma patients
    Lee, Sung-Eun
    Jeon, Young-Woo
    Yoon, Jae-Ho
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong Wook
    Min, Woo-Sung
    Kim, Myungshin
    Min, Chang-Ki
    THROMBOSIS RESEARCH, 2015, 136 (05) : 974 - 979
  • [40] Frequency and coexistence of recurrent chromosomal aberrations in multiple myeloma patients
    Rebersek, Katarina
    Cernelc, Peter
    Podgornik, Helena
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (11): : 764 - 768
12345